Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
Digital Intelligence roundup
Includes Pfizer’s Dupuytren’s disease campaign, a Facebook app from ViroPharma, new marketing spend analysis and a digital tip of the week. ... US-based biopharma company ViroPharma has launched a Facebook app to encourage the testing and diagnosis
Oncology bias in pharma deals
With these two deals, ViroPharma continues to build a presence in the metabolic and CNS franchises for niche and orphan diseases. ... polymerase inhibitor) in phase II for HCV. 230. DuoCort Pharma/ViroPharma. Company acquisition.
WCG named Global Healthcare Agency of the Year
The agency now serves the international communications needs of many multi-national companies, including Pfizer, Boston Scientific, Bayer, Genomic Health and ViroPharma. .
Drug delivery
In the drug delivery space, quickly following its deal with ViroPharma in May, Halozyme licensed its Enhanze technology to Interexon to develop a sub-cutaneous alpha 1-antitrypsin replacement therapy.
Eastern Europe targeted
Divestment. 120. ViroPharma/Halozyme. Drug delivery platform using recombinant human hyaluronidase enzyme (rHuPH20) technology.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
-
Account Manager
-
Competitive salary with bonus and benefits
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Home or away: where next for pharmaceutical symposia?
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- FDA grants priority review for Roche’s Evrysdi for spinal muscular atrophy in babies
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- Pfizer’s Paxlovid receives positive opinion from CHMP
- Moderna begins phase 2 trial of Omicron-specific booster
- Expanding Access to High-Quality Healthcare
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Janssen’s Tremfya receives positive results for active psoriatic arthritis
- ARISE - a strategic healthcare communication planning process from Bedrock
PMHub
ahair@onyxhealth.com
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Personalised medicine: driving a need for greater diversity in clinical trials
- Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
